Join us at World CB & CDx 2025
AI Pathology and Spatial Biomarker Solutions for Clinical Trials and Diagnostics
Enabling next-gen diagnostics for ADCs, multi-specifics, and IO.
Talk:
Novel ADC Insights to Inform Your Biomarker & CDx Strategy
- Date: Thursday, September 25, 2025
- Time: 11 AM EST
Abstract Highlights:
- New research on how an antibody-drug conjugate (ADC) can bypass internalization, leading to the bystander effect
- How the tumor microenvironment and immune interactions could influence patient stratification and ADC-immunotherapy combo strategies
- How AI spatial proteomics and IHC, H&E-based quantitative biomarker scoring can give deeper insights into the MOA and efficacy of ADCs
Speaker
Ken Bloom, MD, FCAP
Head of Pathology
Nucleai
Book a Meeting with Us
Byron Lawson
VP, Pharma BD & Strategic Partnerships
Grainger Greene
Head of Product
Ken Bloom
Head of Pathology
Please complete the form below to schedule a meeting with our team at World CB & CDx 2025